Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40.

作者: Mary A. Moon , Deborah J. Schuman , Nancy J. Brown , Josephine Thomas , Margaret Boone

DOI:

关键词:

摘要: This Treatment Improvement Protocol (TIP), Clinical Guidelines for the Use of Buprenorphine in Opioid Addiction, provides consensus‐ and evidence‐based treatment guidance use buprenorphine, a new option opioid addiction. The goal this TIP is to provide physicians with information they can make practical informed decisions about buprenorphine treat These guidelines address pharmacology physiology opioids, addiction, buprenorphine; describe patient assessment choice addiction options; detailed protocols withdrawal maintenance therapy include on special populations, e.g., pregnant women, adolescents, polysubstance users. represents another step by Center Substance Abuse (CSAT) toward its bringing national leaders together improve substance disorder United States.

参考文章(80)
Comparison of buprenorphine and methadone in the treatment of opioid dependence American Journal of Psychiatry. ,vol. 151, pp. 1025- 1030 ,(1994) , 10.1176/AJP.151.7.1025
Navaline H, Metzger Ds, McLellan At, O'Brien Cp, Woody Ge, Stolley P, Druley P, Abrutyn E, DePhilippis D, Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes. ,vol. 6, pp. 1049- 1056 ,(1993)
James O. Prochaska, Carlo C. DiClemente, John C. Norcross, In Search of the Structure of Change Springer, New York, NY. pp. 87- 114 ,(1992) , 10.1007/978-1-4612-2922-3_5
John C Higgins-Biddle, Thomas Babor, John B Saunders, Maristela G Monteiro, AUDIT - The alcohol use disorders identification test: guidelines for use in primary care. World Health Organizaton Department of Mental Health and Substance Abuse. ,(2001)
C C DiClemente, J O Prochaska, Stages of change in the modification of problem behaviors. Progress in behavior modification. ,vol. 28, pp. 183- 218 ,(1992)
J. M. Gaulier, P. Marquet, E. Lacassie, J. L. Dupuy, G. Lachatre, Fatal intoxication following self-administration of a massive dose of buprenorphine. Journal of Forensic Sciences. ,vol. 45, pp. 226- 228 ,(2000) , 10.1520/JFS14667J
Scott Cw, DiClemente Cc, Stages of change: interactions with treatment compliance and involvement. NIDA research monograph. ,vol. 165, pp. 131- 156 ,(1997)
G E Bigelow, E C Strain, K L Preston, I A Liebson, Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. Journal of Pharmacology and Experimental Therapeutics. ,vol. 261, pp. 985- 993 ,(1992)